Skip to main content

Agora
Sign in

House bill · H.R. 10857 (119th Congress)

To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and…

U.S. House of Representatives

Latest action Oct 22, 2026

Sponsor: Jake Auchincloss (U.S. Representative, MA-4, Democratic)

Official titleShow

To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.

The heading above is this same sentence with its legal opening removed. No words were added, changed or reordered.

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Oct 24, 2026. About our data

Summary

There is no summary of this item on Agora. The official record has its full text.

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Also referred to House Committee on Ways and Means · U.S. House of Representatives.

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Sign in or create an account to give your position

Full history

  1. Oct 22, 2026

    Introduced

    Introduced in House

    U.S. House of Representatives

  2. Oct 22, 2026

    Introduced

    Introduced in U.S. House

    U.S. House

  3. Oct 22, 2026

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Read the record